- Bureau of Clinical Laboratories Home
- About Us
- Mobile Laboratory
- Chemistry
- Microbiology
- Mycobacteriology and Mycotics Division
- Newborn Screening
- Quality Management
- Sanitary Bacteriology
- Sexually Transmitted Diseases (STD)
- Technical Bulletins
- Laboratory Training
- Environmental Payment Portal
- BCL Webportal
- Contact Us
Mobile Clinical Branch
The Clinical Branch provides Syphilis, Chlamydia trachomatis, Neisseria gonorrhea, Trichomonas vaginalis, and Urine Culture and Sensitivity analysis for BCL healthcare providers. Cinical specimens are tested within the compliance guidelines of the Clinical Laboratory Improvement Amendments (CLIA). Acceptable specimen types and submission guidance can be located in The Analytes Offered by BCL.
Syphilis Serology Section
The Syphilis Section uses the reverse algorithm for testing specimens. The screening procedure is a multiplex flow immunoassay for qualitative detection of total (IgG/IgM) antibodies to Treponema pallidum. A flocculation card test is used for detecting and titering non-treponemal reagin antibodies. If necessary, specimens will be tested using a second treponemal test, the Treponema pallidum - Particle Agglutination (TP-PA) assay.
Chlamydia trachomatis/Neisseria gonorrhea/Trichomonas vaginalis (CT/GC/TV) Section
The CT/GC/TV Section performs testing for Chlamydia trachomatis, Neisseria gonorrhea, and Trichomonas vaginalis using a single specimen to conduct nucleic acid amplification tests (NAAT) on the Hologic Panther System. Specimens must be collected using a Hologic Aptima collection kit. Collection kits can be requested using the BCL Requisition for Containers and Kits form.
Urine Culture and Sensitivity Section
Urine Culture and Sensitivity is a state-wide program responsible for identifying and quantifying bacteria which can cause urinary tract infections. In addition, anti-microbial susceptibilities are given using modern instrumentation to provide accurate values for antibiotic treatment against these bacteria. Compliance with federal guidelines is employed following Clinical Laboratory Standards and the Clinical Laboratory Improvement Amendments (CLIA).
Proper specimen transport time is critical in maintaining the integrity of specimens, and specimen integrity may be compromised if they are not received in the laboratory within 48 hours after collection. Instructions for proper collection and transport are available to facilitate the accuracy of results.
Urine Collection and Transport Instructions
See also, Mobile Environmental Branch and Shellfish Branch.
Page last updated: September 28, 2026

